Loading
Life sciences · Journal article
Moscow University Chemistry Bulletin · October 26, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Neurodegenerative diseases, characterized by irreversible decline in cognitive function, attract significant attention from researchers. Based on their symptomatic and pathophysiological features, these diseases are classified into several main groups, with Alzheimer’s, Parkinson’s, and Huntington’s diseases being the most prevalent. Since the key effector (initiator) of the pathological process remains unknown for most of these conditions, multiple alternative hypotheses attempt to explain their mechanisms. This review presents the infectious origin hypothesis of neurodegenerative diseases and the current state of supporting evidence. The strengths and weaknesses of this hypothesis were discussed, and based on the proposed etiology, existing therapeutic approaches were outlined, along with potential methods for their improvement. For instance, the use of broad-spectrum antimicrobial agents demonstrated low efficacy, highlighting the need for the development of more targeted, specialized, and advanced treatments.